Effect of inhibiting carnitine biosynthesis on male rat sexual performance

Physiology and Behavior

Volumn 95, Issue 3, 2008, Pages 341-347

  Dambrova, Maija ^a   Cirule, Helena ^a   Svalbe, Baiba ^a,b   Zvejniece, Liga ^a,b   Pugovichs, Osvalds ^a   Zorenko, Tatjana ^b   Kalvinsh, Ivars ^a   Liepinsh, Edgars ^a,b   Belozertseva, Irina ^c  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^b UNIVERSITY OF LATVIA   (Latvia)

^c PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

butyrobetaine; Carnitine; Male rat; Mildronate; Sexual behavior; Sperm; Testes

Indexed keywords

CARNITINE; CARNITINE PALMITOYLTRANSFERASE; GAMMA BUTYROBETAINE; MILDRONATE; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SCIENCE; BIOSYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EPIDIDYMIS; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RAT; SEXUAL BEHAVIOR; SPERM; SPERMATOZOON; SPERMATOZOON MOTILITY; TESTIS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; BEHAVIOR, ANIMAL; BETAINE; CARNITINE; CHROMATOGRAPHY, LIQUID; CHYMASES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHYLHYDRAZINES; RATS; SEXUAL BEHAVIOR, ANIMAL; SPERM MOTILITY; SPERMATOZOA; TANDEM MASS SPECTROMETRY; TESTOSTERONE; TIME FACTORS;

EID: 52949141438     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2008.06.012     Document Type: Article

References (39)

1. Foster D.W. The role of the carnitine system in human metabolism. Ann N Y Acad Sci 1033 (2004) 1-16
2. Rebouche C.J. Carnitine function and requirements during the life cycle. FASEB J 6 (1992) 3379-3386
3. Marson J., Meuris S., Cooper R.W., and Jouannet P. Puberty in the male chimpanzee: progressive maturation of semen characteristics. Biol Reprod 44 (1991) 448-455
4. Rebouche C.J., Mack D.L., and Edmonson P.F. l-carnitine dissimilation in the gastrointestinal tract of the rat. Biochemistry 23 (1984) 6422-6426
5. Bieber L.L. Carnitine. Annu Rev Biochem 57 (1988) 261-283
6. Carter A.L., Abney T.O., Braver H., and Chuang A.H. Localization of gamma-butyrobetaine hydroxylase in the rat testis. Biol Reprod 37 (1987) 68-72
7. Jeulin C., and Lewin L.M. Role of free l-carnitine and acetyl-l-carnitine in post-gonadal maturation of mammalian spermatozoa. Hum Reprod Update 2 (1996) 87-102
8. Ng C.M., Blackman M.R., Wang C., and Swerdloff R.S. The role of carnitine in the male reproductive system. Ann N Y Acad Sci 1033 (2004) 177-188
9. Agarwal A., and Said T.M. Carnitines and male infertility. Reprod Biomed Online 8 (2004) 376-384
10. Sinclair S. Male infertility: nutritional and environmental considerations. Altern Med Rev 5 (2000) 28-38
11. Morano S., Mandosi E., Fallarino M., Gatti A., Tiberti C., Sensi M., et al. Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. Eur Urol 52 (2007) 1768-1774
12. Li K., Li W., Huang Y.F., and Shang X.J. Level of free l-carnitine in human seminal plasma and its correlation with semen quality. Zhonghua Nan Ke Xue 13 (2007) 143-146
13. Cavallini G., Caracciolo S., Vitali G., Modenini F., and Biagiotti G. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology 63 (2004) 641-646
14. Costa M., Canale D., Filicori M., D'lddio S., and Lenzi A. l-carnitine in idiopathic asthenozoospermia: a multicenter study. Italian Study Group on Carnitine and Male Infertility. Andrologia 26 (1994) 155-159
15. Kumar R., Gautam G., and Gupta N.P. Drug therapy for idiopathic male infertility: rationale versus evidence. J Urol 176 (2006) 1307-1312
16. Lenzi A., Sgro P., Salacone P., Paoli D., Gilio B., Lombardo F., et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril 81 (2004) 1578-1584
17. Lenzi A., Lombardo F., Sgro P., Salacone P., Caponecchia L., Dondero F., et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril 79 (2003) 292-300
18. Liepinsh E., Vilskersts R., Loca D., Kirjanova O., Pugovichs O., Kalvinsh I., et al. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction. J Cardiovasc Pharmacol 48 (2006) 314-319
19. Kalvinsh I., Veveris M., and Birmans A. Pharmaceutial composition comprising gamma-butyrobetaine for stimulating the sexual activity and potency (2003) WO/2003/022263[WO/2003/022263], Ref Type: Patent
20. Bohmer T. Accumulation of carnitine in rat epididymis after injection of [3H]butyrobetaine in vivo: quantitative aspects, and the effects of androgens and antiandrogens. Mol Cell Endocrinol 11 (1978) 213-223
21. Pechersky A.V., Mazurov V.I., Semiglazov V.F., Karpischenko A.I., Mikhailichenko V.V., and Udintsev A.V. Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume. Int J Androl 25 (2002) 119-125 Ref Type: Journal (Full)
22. Simkhovich B.Z., Shutenko Z.V., Meirena D.V., Khagi K.B., Mezapuke R.J., Molodchina T.N., et al. 3-(2,2,2-Trimethylhydrazinium)propionate (THP)-a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties. Biochem Pharmacol 37 (1988) 195-202
23. Kuwajima M., Harashima H., Hayashi M., Ise S., Sei M., Lu K., et al. Pharmacokinetic analysis of the cardioprotective effect of 3-(2,2, 2-trimethylhydrazinium) propionate in mice: inhibition of carnitine transport in kidney. J Pharmacol Exp Ther 289 (1999) 93-102
24. Spaniol M., Brooks H., Auer L., Zimmermann A., Solioz M., Stieger B., et al. Development and characterization of an animal model of carnitine deficiency. Eur J Biochem 268 (2001) 1876-1887
25. Maeda T., Goto A., Kobayashi D., and Tamai I. Transport of organic cations across the blood-testis barrier. Mol Pharmacol 4 (2007) 600-607
26. Grube M., Meyer zu Schwabedissen H.E., Prager D., Haney J., Moritz K.U., Meissner K., et al. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 113 (2006) 1114-1122
27. Agmo A. Male rat sexual behavior. Brain Res Brain Res Protoc 1 (1997) 203-209
28. World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction (1999), Cambridge University Press, Cambridge 1-128
29. Hayashi Y., Muranaka Y., Kirimoto T., Asaka N., Miyake H., and Matsuura N. Effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on tissue carnitine and lipid levels in rats. Biol Pharm Bull 23 (2000) 770-773
30. Degrace P., Demizieux L., Gresti J., Tsoko M., Andre A., Demaison L., et al. Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat. Mol Cell Biochem 258 (2004) 171-182
31. Akahira M., Hara A., and Abiko Y. Effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on myocardial derangements induced by hydrogen peroxide in the isolated perfused rat heart. Fundam Clin Pharmacol 11 (1997) 356-364
32. Rigault C., Dias J.V., Demarquoy J., and Le B.F. Characteristics of l-carnitine import into heart cells. Biochimie 90 (2008) 542-546
33. Degrace P., Demizieux L., Du Z.Y., Gresti J., Caverot L., Djaouti L., et al. Regulation of lipid flux between liver and adipose tissue during transient hepatic steatosis in carnitine-depleted rats. J Biol Chem 282 (2007) 20816-20826
34. Cederblad G. Plasma carnitine and body composition. Clin Chim Acta 67 (1976) 207-212
35. Dambrova M., Liepinsh E., and Kalvinsh I. Mildronate: cardioprotective action through carnitine-lowering effect. Trends Cardiovasc Med 12 (2002) 275-279
36. Sjakste N., Gutcaits A., and Kalvinsh I. Mildronate: an antiischemic drug for neurological indications. CNS Drug Rev 11 (2005) 151-168
37. Dzintare M., Baumane L., Meirena D., Lauberte L., Kalvinsh I., and Sjakste N. Involvement of nitric oxide production in the mildronate mechanism of action. Pharmacol Rev Commun 12 (2002) 163-170
38. Dzintare M. Changes of concentration of nitric oxide in tissues under action of different pharmacological agents (2004), University of Latvia, Riga 1-76
39. Benelli A., Bertolini A., Poggioli R., Cavazzuti E., Calza L., Giardino L., et al. Nitric oxide is involved in male sexual behavior of rats. Eur J Pharmacol 294 (1995) 505-510